版本:
中国

BRIEF-Merrimack announces completion of enrollment in phase 2 carrie study of mm-141

June 19 Merrimack Pharmaceuticals Inc

* Merrimack announces completion of enrollment in phase 2 carrie study of mm-141; data expected in first half of 2018 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐